Epidemiological Investigation of Malocclusion in China
Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Apr 2, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Epidemiological Investigation of Malocclusion in China" is focused on studying malocclusion, which is a dental condition where teeth are not properly aligned. This can happen for various reasons, including genetics, environment, or habits. It's been over twenty years since comprehensive data on how common this issue is in China has been collected, and as things may have changed, this study aims to gather updated information to better understand malocclusion in the population.
To participate in this trial, individuals aged between 14 and 73 who are generally healthy and have not previously received orthodontic treatment (like braces) or had jaw surgery may be eligible. Participants will need to agree to sign a consent form and should be able to complete oral examinations and questionnaires. The trial is not yet recruiting participants, but once it starts, those who join can expect to contribute to important research that could help improve dental health awareness and treatment options in China.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Individuals with all genders;
- • 2. Individuals with good general health;
- • 3. Individuals with no history of orthodontic treatment or other maxillofacial surgical interventions;
- • 4. Individuals who agree to and are willing to sign the informed consent form.
- Exclusion Criteria:
- • 1. Individuals diagnosed with genetic or systemic disorders;
- • 2. Individuals with a recent (within the past 3 months) history of maxillofacial trauma;
- • 3. Individuals who are incapable of undergoing oral examinations or completing the necessary questionnaires.
About Shanghai Jiao Tong University School Of Medicine
Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Bing Fang, PhD
Principal Investigator
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported